(n){if(!window.cnxel){window.cnxel={},window.cnxel.cmd=[];var t=n.createElement('iframe');t.src='javascript:false'; t.display='none',t.onload=function(){var ...

Fact checked by Jennifer Klump Key Takeaways Insulin costs have declined over the past two years, and additional price cuts ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. U.S. regulators took action Wednesday that ...

WASHINGTON (AP) - U.S. regulators took action Wednesday that will make it easier to get a cheaper, near-copy of a brand-name insulin at the drugstore. Doctors now have to specifically prescribe what’s ...

Prices for insulin, the essential drug for treating diabetes, have plummetted to their lowest levels in a decade following a rise in generic options. Insulin prices averaged 19 cents per unit as of ...

Key Takeaways California’s CalRx insulin pens will launch Jan. 1 at $11 each, or $55 for a five-packThe state has invested $100 million to lower insulin costsThe effort could save patients $2,000 to ...

Scientists have designed a new form of insulin that can automatically switch itself on and off depending on glucose levels in the blood. In animals, this ‘smart’ insulin 1 reduced high blood-sugar ...

California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say ...

A comprehensive study presented at the Endocrine Society’s ENDO 24 annual meeting has revolutionized understanding of diabetes management during pregnancy. Following 10,117 mother-child pairs for up ...

After slashing the U.S. prices of several of its insulin products by 75% at the start of 2024, Novo Nordisk is ending the year by announcing similar price reductions for most of its other insulins for ...

Please provide your email address to receive an email when new articles are posted on . Of 11,758 patients with CKD, diabetes and hypertension in the study, researchers found 1,285 cases of dementia.

U.S. regulators took action Wednesday that will make it easier to get a cheaper, near-copy of brand-name insulin at the drugstore. Doctors now have to specifically prescribe what’s called a biosimilar ...